Thursday November 26 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Bone Resorption

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Bone Resorption:

Pubmed Logo
Role of CX3CL1/Fractalkine in Osteoclast Differentiation and Bone Resorption.
The recruitment of osteoclast precursors toward osteoblasts and subsequent...
20th November, 2009
*Division of Pathogenic Biochemistry, Institute of Natural Medicine. J Immunol. 2009 Nov 18.
DOI Direct Link
Osteoprotegerin in relation to type 2 diabetes mellitus and the metabolic syndrome in postmenopausal women.
Osteoprotegerin (OPG) is an inhibitor of bone resorption. Circulating...
20th November, 2009
Department of Endocrine and Metabolic Diseases, The Persian Gulf Tropical Metabolism. 2009 Nov 17.
DOI Direct Link
Connective tissue growth factor promotes articular damage by increased osteoclastogenesis in patients with rheumatoid arthritis.
ABSTRACT: INTRODUCTION: A protein analysis using a mass spectrometry...
20th November, 2009
Arthritis Res Ther. 2009 Nov 18;11(6):R174.
DOI Direct Link
High pressure may inhibit periprosthetic osteogenesis.
Mechanical effects have been demonstrated to activate periprosthetic...
19th November, 2009
Department of Orthopaedics, Shanghai 6th Hospital, Shanghai Jiaotong J Bone Miner Metab. 2009 Nov 17.
DOI Direct Link
Computational simulation of spontaneous bone straightening in growing children.
Periosteal surface pressures have been shown to inhibit bone formation and...
19th November, 2009
Bone and Joint Center, Veterans Affairs Palo Alto Health Care System, 3801 Biomech Model Mechanobiol. 2009 Nov 18.
DOI Direct Link

View more research publications.

Press Releases About Bone Resorption:

BioPortfolio Logo
ASH Announces 2009 Merit Award Winners 25th November, 2009 American Society of Hematology
WASHINGTON, Nov. 25 /PRNewswire-USNewswire/ -- The American Society of Hematology (ASH) is pleased to recognize the following abstract presenters with the highest scoring abstracts in the categories
US Trauma Fixation Device Market Not Seeing Signs of Slowdown 25th November, 2009 Millennium Research Group
WALTHAM, Mass., Nov. 25 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the nearly $3 billion US market for trauma
Reportlinker Adds Regenerative Medicine - Global Market Trends 25th November, 2009 Reportlinker
NEW YORK, Nov. 25 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Regenerative Medicine - Global Market Trends http://www.reportlinker.com
Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 24th November, 2009
DUBLIN, November 24 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced that it has submitted a MAA to the European Medicines Agency
Mass Eye & Ear's Temporal Bone Registry Website Gets A Face Lift 23rd November, 2009 Professional Web Solutions, LLC
ACTON, Mass., Nov. 23 /PRNewswire/ -- Professional Web Solutions, LLC who designs, develops and hosts websites for businesses and non-profit organizations has just unveiled a new look for The NIDCD

BioNews Results for Bone Resorption:

RSS Logo
BioPortfolio Logo
Increase of Bone Resorption and the Parathyroid Hormone in Postmenopausal Women in the Long-term after Roux-en-Y Gastric Bypass
MDLinx:  Nov 4 2009 10:53AM Matching: bone resorption

Bone Resorption Patents:

USPTO Logo
US Patent No.Title
7598370 siRNA targeting polo-like kinase-1 (PLK-1)
7605246 Genes differentially expressed in breast cancer
7605250 siRNA targeting cAMP-specific phosphodiesterase 4D
7605252 siRNA targeting kinase insert domain receptor (KDR)
7605261 Urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and novel use

View more patents.

Companies working in the area of Bone Resorption from Bioportfolio's Biocorporate database :

BioPortfolio Logo
Company Name

Callisto Pharmaceuticals, Inc.

Callisto Pharmaceuticals, Inc., is a publicly traded biotechnology company on the American Stock Exchange (AMEX:KAL) and Frankfurt Exchange (CA4). Callisto's primary focus is the clinical development...
www.callistopharma.com/        View full profile
Thumbshot

BioPortfolio Ltd. offers e-mail and postal lists for Bone Resorption scientists - we have details of around 2255 individuals working on Bone Resorption .


This page has been viewed 394 times
Recent Search Terms used to find this page: celebrity publicly traded biotechnology companies | bone resorption | bisphosphonate administration prior to tooth extractiondelays initial healing pdf | dental resorption | Bone resorption diseases | dental-bone-resorption | bone resorption | dental bone resorption 2009 | metismedica | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Bone Resorption across BioPortfolio, or for Bone Resorption Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.